Scientists hunt for clues in blood and skin to unlock scleroderma mysteries
NCT ID NCT07345052
Summary
This study aims to discover what causes systemic sclerosis (scleroderma) and find markers that can predict how the disease will progress or respond to treatment. Researchers will collect and analyze blood, skin, and DNA samples from 150 patients in Sweden. The goal is to identify specific genes, proteins, and immune cells linked to the disease to help develop better future treatments and diagnostic tools.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FIBROSIS; SKIN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Rheumatology clinics, Sahlgrenska University Hospital
RECRUITINGGothenburg, Sweden, 41346, Sweden
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.